Goldman Sachs
LMAT icon

Goldman Sachs’s LeMaitre Vascular LMAT Stock Holding History

Goldman Sachs’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.2M Buy
432,416
+41,162
+11% +$3.92M 0.01% 1618
2025
Q4 		$31.7M Buy
391,254
+231,157
+144% +$19.9M ﹤0.01% 1920
2025
Q3 		$14M Sell
160,097
-29,174
-15% -$2.61M ﹤0.01% 2632
2025
Q2 		$15.7M Sell
189,271
-73,174
-28% -$6.12M ﹤0.01% 2343
2025
Q1 		$22M Buy
262,445
+55,804
+27% +$5.19M ﹤0.01% 1947
2024
Q4 		$19M Buy
206,641
+81,573
+65% +$7.84M ﹤0.01% 2178
2024
Q3 		$11.6M Buy
125,068
+55,013
+79% +$4.77M ﹤0.01% 2568
2024
Q2 		$5.76M Sell
70,055
-241
-0.3% -$17.7K ﹤0.01% 3021
2024
Q1 		$4.66M Buy
70,296
+23,836
+51% +$1.47M ﹤0.01% 3153
2023
Q4 		$2.64M Sell
46,460
-36,317
-44% -$1.9M ﹤0.01% 3707
2023
Q3 		$4.51M Sell
82,777
-37,987
-31% -$2.25M ﹤0.01% 3076
2023
Q2 		$8.13M Buy
120,764
+32,620
+37% +$1.99M ﹤0.01% 2650
2023
Q1 		$4.54M Buy
88,144
+26,888
+44% +$1.31M ﹤0.01% 3156
2022
Q4 		$2.82M Sell
61,256
-25,199
-29% -$1.18M ﹤0.01% 3659
2022
Q3 		$4.38M Sell
86,455
-40,233
-32% -$2.01M ﹤0.01% 3241
2022
Q2 		$5.77M Sell
126,688
-26,096
-17% -$1.17M ﹤0.01% 3002
2022
Q1 		$7.1M Buy
152,784
+2,275
+2% +$102K ﹤0.01% 3018
2021
Q4 		$7.56M Sell
150,509
-75,030
-33% -$3.88M ﹤0.01% 3015
2021
Q3 		$12M Buy
225,539
+14,249
+7% +$803K ﹤0.01% 2546
2021
Q2 		$12.9M Buy
211,290
+110,593
+110% +$5.87M ﹤0.01% 2451
2021
Q1 		$4.91M Buy
100,697
+42,591
+73% +$2M ﹤0.01% 3152
2020
Q4 		$2.35M Buy
58,106
+4,566
+9% +$163K ﹤0.01% 3613
2020
Q3 		$1.74M Buy
53,540
+4,386
+9% +$132K ﹤0.01% 3661
2020
Q2 		$1.3M Sell
49,154
-28,237
-36% -$738K ﹤0.01% 3778
2020
Q1 		$1.93M Sell
77,391
-5,326
-6% -$164K ﹤0.01% 3336
2019
Q4 		$2.97M Buy
82,717
+62,623
+312% +$2.16M ﹤0.01% 3361
2019
Q3 		$687K Buy
+20,094
New +$642K ﹤0.01% 4270
2019
Q2 		– Sell
-106,609
Closed -$3.31M – 5255
2019
Q1 		$3.31M Buy
106,609
+48,184
+82% +$1.29M ﹤0.01% 3279
2018
Q4 		$1.38M Sell
58,425
-24,627
-30% -$673K ﹤0.01% 3781
2018
Q3 		$3.22M Sell
83,052
-13,136
-14% -$473K ﹤0.01% 3281
2018
Q2 		$3.22M Buy
96,188
+32,028
+50% +$1.14M ﹤0.01% 3272
2018
Q1 		$2.32M Buy
64,160
+14,364
+29% +$498K ﹤0.01% 3488
2017
Q4 		$1.59M Sell
49,796
-13,449
-21% -$461K ﹤0.01% 3969
2017
Q3 		$2.37M Buy
63,245
+10,594
+20% +$361K ﹤0.01% 3827
2017
Q2 		$1.64M Buy
52,651
+33,685
+178% +$973K ﹤0.01% 3990
2017
Q1 		$467K Buy
18,966
+5,299
+39% +$124K ﹤0.01% 5096
2016
Q4 		$346K Sell
13,667
-22,529
-62% -$500K ﹤0.01% 5369
2016
Q3 		$718K Buy
36,196
+324
+0.9% +$5.66K ﹤0.01% 4712
2016
Q2 		$512K Buy
35,872
+23,959
+201% +$366K ﹤0.01% 4837
2016
Q1 		$185K Buy
+11,913
New +$171K ﹤0.01% 5679
2015
Q4 		– Sell
-51,588
Closed -$629K – 7267
2015
Q3 		$629K Buy
+51,588
New +$662K ﹤0.01% 4916

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs's LMAT Position: Q1 2026 in Review

Goldman Sachs increased its LeMaitre Vascular (LMAT) stake by 11% in Q1 2026, buying an estimated $3.92M and bringing the position to 432,416 shares worth $47.2M. The position accounts for 0.01% of the portfolio, ranked #1618.

Goldman Sachs first reported a position in LMAT in Q3 2015 and has held it in 41 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Goldman Sachs held 432,416 shares of LeMaitre Vascular worth $47.2M as of Q1 2026.
  • Goldman Sachs bought 41,162 LeMaitre Vascular shares in Q1 2026, an estimated $3.92M.
  • LeMaitre Vascular made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1618 holding.
  • Goldman Sachs first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 41 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.